The company
The Monarc Bionetworks’ multi-discipline team of drug development and digital technology experts have created a comprehensive end-to-end clinical research platform that enables earlier and broader collaboration between patients, providers, and researchers to accelerate drug development exponentially. Monarc Bionetworks’ integrated research platform and approach exponentially accelerate clinical trial cycle times by transforming a highly sequential and siloed drug development model into an integrated and collaborative model between patients, providers, and researchers without sacrificing the principles of evidence-based medicine, Monarc Bionetworks converges clinical practice with clinical care to accelerate research and adoption of medical innovations and new quality standards.